No abstract

NTproBNP appears to be a good screening tool to determine the onset of BPD-PH as early as 28 weeks CGA.

We report twin neonates who were born prematurely at 32 weeks of gestation to a mother with human immunodeficiency virus infection. One of the twins developed complete heart block and dilated cardiomyopathy related to lopinavir/ritonavir therapy, a boosted protease-inhibitor agent, while the other twin developed mild bradycardia. We recommend caution in the use of lopinavir/ritonavir in the immediate neonatal period.

HsPDA leads to increased hsTnT and NTproBNP levels in preterm infants without affecting cardiac function.

No abstract